Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 15/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8938844 | 0.88 | ACHE (1.00) | ACHE | |
| SCHEMBL6936357 | 0.83 | ACHE (1.00) | ACHE | |
| SCHEMBL29621066 | 0.82 | ACHE (0.61) | ACHE | |
| SCHEMBL3658017 | 0.82 | ACHE (0.61) | ACHE | |
| SCHEMBL16913352 | 0.82 | ACHE (0.76) | ACHE | |
| SCHEMBL16913351 | 0.82 | ACHE (0.76) | ACHE | |
| SCHEMBL30666981 | 0.82 | ACHE (0.53) | ACHE | |
| SCHEMBL21888375 | 0.80 | ACHE (0.78) | ACHE | |
| SCHEMBL3747171 | 0.80 | ACHE (0.71) | ACHE | |
| SCHEMBL19313326 | 0.79 | ACHE (0.57) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2004664-B1 | METALLOCENE COMPOUNDS | BASELL POLYOLEFINE GMBH (DE) | 2016-12-14 | — | — | EP | disclosed |
| US-7834205-B2 | Metallocene compounds | Basell Polyolifine GmbH (DE) | 2010-11-16 | — | — | US | disclosed |
| US-20090275712-A1 | Metallocene Compounds | BASELL POLYOLEFINE GMBH (DE) | 2009-11-05 | — | — | US | disclosed |
| EP-2004664-A1 | METALLOCENE COMPOUNDS | Basell Polyolefine GmbH (DE) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007116034-A1 | METALLOCENE COMPOUNDS | BASELL POLYOLEFINE GMBH (DE) | 2007-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275712-A1 | Metallocene Compounds | MT-CO3, SOD1, MT-CO1 | ACHE 4043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.